Consonance-HFW Acquisition Corp.

Status: Deal Closed
U=S+W/3 W=S@11.5
IPO Proceeds, $M $92.00M
IPO Date Nov 19, 2020
CEO Gad Soffer
Left Lead JP Morgan
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Life sciences

IPO Geography Global
Target Company Surrozen
Deal Announced Apr 15, 2021
Deal Size, $M $203.30M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Aug 10, 2021
Amendment Vote TBD
Closing Date Aug 11, 2021
Formerly CHFW SRZN SRZNW

Sign up for Free Trial

No credit card required

Sign in for more on Consonance-HFW Acquisition Corp.:

  • Structure and cap table
  • 8 directors & officers
  • 22 filings and events
  • 1 underwriters
  • 5 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Dr. Mitchell Blutt, M.D. 63 Chairman
Gad Soffer 44 CEO
Kevin Livingston 49 CFO
Dr. Benny Soffer, M.D. 47 Director
Joshua House 39 VP Business Development
Donald J. Santel 60 Director
Dr. Christopher Haqq, M.D., Ph.D. 54 Director
Jennifer Jarrett 49 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
JP Morgan BR 8,000,000 units
8,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 22 filings.

Shareholders

Sign in to view shareholders 13F filing data.